Lifecore Biomedical Inc.
Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization that serves customers in the United States, Belgium, the Netherlands, and internationally. It offers services in the development, manufacture, aseptic fill, and finish of formulations and highly viscous sterile injectable pharmaceutical drug or medical device pr… Read more
Lifecore Biomedical Inc. (LFCR) - Total Liabilities
Latest total liabilities as of August 2025: $198.42 Million USD
Based on the latest financial reports, Lifecore Biomedical Inc. (LFCR) has total liabilities worth $198.42 Million USD as of August 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
Lifecore Biomedical Inc. - Total Liabilities Trend (1996–2025)
This chart illustrates how Lifecore Biomedical Inc.'s total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
Lifecore Biomedical Inc. Competitors by Total Liabilities
The table below lists competitors of Lifecore Biomedical Inc. ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Kejuruteraan Asastera Bhd
KLSE:0193
|
Malaysia | RM317.06 Million |
|
Summit Bank Group Inc
PINK:SBKO
|
USA | $1.13 Billion |
|
Sea1 Offshore Inc.
OL:SEA1
|
Norway | Nkr405.15 Million |
|
Samhwa Paint
KO:000390
|
Korea | ₩291.59 Billion |
|
Suzhou Goldengreen Technologies Ltd
SHE:002808
|
China | CN¥235.98 Million |
|
Galaxy Software Services Corporation
TWO:6752
|
Taiwan | NT$1.28 Billion |
|
Quang Viet Enterprise Co Ltd
TW:4438
|
Taiwan | NT$12.00 Billion |
Liability Composition Analysis (1996–2025)
This chart breaks down Lifecore Biomedical Inc.'s total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.80 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 5.39 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.84 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Lifecore Biomedical Inc.'s debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Lifecore Biomedical Inc. (1996–2025)
The table below shows the annual total liabilities of Lifecore Biomedical Inc. from 1996 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-05-31 | $238.01 Million | -1.91% |
| 2024-05-31 | $242.65 Million | +29.84% |
| 2023-05-31 | $186.88 Million | -0.18% |
| 2022-05-31 | $187.22 Million | -37.62% |
| 2021-05-31 | $300.14 Million | -3.26% |
| 2020-05-31 | $310.27 Million | +24.63% |
| 2019-05-31 | $248.95 Million | +63.63% |
| 2018-05-31 | $152.14 Million | +17.16% |
| 2017-05-31 | $129.86 Million | -0.96% |
| 2016-05-31 | $131.12 Million | +3.77% |
| 2015-05-31 | $126.36 Million | +16.07% |
| 2014-05-31 | $108.86 Million | -1.51% |
| 2013-05-31 | $110.53 Million | -12.37% |
| 2012-05-31 | $126.13 Million | +83.91% |
| 2011-05-31 | $68.59 Million | +1.28% |
| 2010-05-31 | $67.72 Million | +163.82% |
| 2009-05-31 | $25.67 Million | -25.75% |
| 2008-05-31 | $34.57 Million | +18.02% |
| 2007-05-31 | $29.30 Million | -9.04% |
| 2006-05-31 | $32.20 Million | +21.30% |
| 2005-05-31 | $26.55 Million | -11.23% |
| 2004-05-31 | $29.91 Million | -20.40% |
| 2003-05-31 | $37.57 Million | -25.25% |
| 2002-05-31 | $50.26 Million | -27.42% |
| 2001-05-31 | $69.25 Million | +3.77% |
| 2000-05-31 | $66.73 Million | +649.82% |
| 1999-05-31 | $8.90 Million | +2.30% |
| 1998-05-31 | $8.70 Million | -40.41% |
| 1997-05-31 | $14.60 Million | +711.11% |
| 1996-05-31 | $1.80 Million | -- |